Back
  1. Home
  2. Profile of Stéphanie Humblet (ULiège)
Profil

Humblet Stéphanie

See author's contact details
Main Referenced Co-authors
Baron, Frédéric  (9)
Beguin, Yves  (7)
Rawlings, D. J. (5)
Astrakhan, A. (3)
Fillet, Georges  (3)
Main Referenced Keywords
Humans (3); Adult (2); hematopoietic cell transplantation (2); Male (2); age (1);
Main Referenced Unit & Research Centers
GIGA-I3 - Giga-Infection, Immunity and Inflammation - ULiège [BE] (1)
Main Referenced Disciplines
Hematology (14)
Immunology & infectious disease (2)

Publications (total 16)

The most downloaded
1825 downloads
Tian, L., De Hertogh, G., Fedeli, M., Staats, K. A., Schonefeldt, S., Humblet, S., Van Den Bosch, L., Dellabona, P., Dooley, J., & Liston, A. (2012). Loss of T cell microRNA provides systemic protection against autoimmune pathology in mice. Journal of Autoimmunity. doi:10.1016/j.jaut.2011.12.004 https://hdl.handle.net/2268/110128

The most cited

159 citations (Scopus®)

Humblet, S., Sather, B., Anover, S., Becker-Herman, S., Kasprowicz, D. J., Khim, S., Nguyen, T., Hudkins-Loya, K., Alpers, C. E., Ziegler, S. F., Ochs, H., Torgerson, T., Campbell, D. J., & Rawlings, D. J. (2007). Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis. Journal of Clinical Investigation, 117 (2), 407-18. doi:10.1172/JCI29539 https://hdl.handle.net/2268/110133

Humblet-Baron, S., Schönefeldt, S., Garcia-Perez, J. E., Baron, F., Pasciuto, E., & Liston, A. (November 2017). Cytotoxic T-lymphocyte-associated protein 4-Ig effectively controls immune activation and inflammatory disease in a novel murine model of leaky severe combined immunodeficiency. Journal of Allergy and Clinical Immunology, 140 (5), 1394-1403.e8. doi:10.1016/j.jaci.2016.12.968
Peer Reviewed verified by ORBi

Ehx, G., Somja, J., Fransolet, G., Delens, L., Muller, J., Beguin, Y., Humblet-Baron, S., & Baron, F. (14 October 2016). Comparison of xenogeneic graft-versus-host reactions in humanized NSG and NSG-HLA-A2/HHD mice [Poster presentation]. Regulatory T cells mini-symposium, Leuven, Belgium.

Tian, L., De Hertogh, G., Fedeli, M., Staats, K. A., Schonefeldt, S., Humblet, S., Van Den Bosch, L., Dellabona, P., Dooley, J., & Liston, A. (2012). Loss of T cell microRNA provides systemic protection against autoimmune pathology in mice. Journal of Autoimmunity. doi:10.1016/j.jaut.2011.12.004
Peer Reviewed verified by ORBi

Humblet, S., Baron, F., & Liston, A. (2011). Regulatory T cells fulfil their promise ? Immunology and Cell Biology, 89, 825-826. doi:10.1038/icb.2011.52
Peer Reviewed verified by ORBi

Sather, B. D., Ryu, B. Y., Stirling, B. V., Garibov, M., Kerns, H. M., Humblet, S., Astrakhan, A., & Rawlings, D. J. (2011). Development of B-lineage predominant lentiviral vectors for use in genetic therapies for B cell disorders. Molecular Therapy, 19 (3), 515-25. doi:10.1038/mt.2010.259
Peer Reviewed verified by ORBi

CASTERMANS, E., Hannon, M., Dutrieux, J., Humblet, S., Seidel, L., Cheynier, R., Willems, E., Gothot, A., Vanbellinghen, J.-F., Geenen, V., Sandmaier, B. M., Storb, R., Beguin, Y., & Baron, F. (2011). Thymic recovery after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning is limited to patients younger than 60 years of age. Haematologica, 96(2), 298-306. doi:10.3324/haematol.2010.029702
Peer Reviewed verified by ORBi

Kerns, H. M., Ryu, B. Y., Stirling, B. V., Sather, B. D., Astrakhan, A., Humblet, S., Liggitt, D., & Rawlings, D. J. (2010). B cell-specific lentiviral gene therapy leads to sustained B-cell functional recovery in a murine model of X-linked agammaglobulinemia. Blood, 115 (11), 2146-55. doi:10.1182/blood-2009-09-241869
Peer Reviewed verified by ORBi

Willems, E., Humblet-Baron, S., Dengis, O., Seidel, L., Beguin, Y., & Baron, F. (2010). Elevations of tumor necrosis factor-receptor-1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Bone Marrow Transplantation, 45, 1442-1448. doi:10.1038/bmt.2009.360
Peer Reviewed verified by ORBi

Humblet-Baron, S. (2009). Regulatory T cells in Wiskott-Aldrich syndrome and after allogeneic transplantation with nonmyeloablative conditioning [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/110441

Meyer-Bahlburg, A., Becker-Herman, S., Humblet, S., Khim, S., Weber, M., Bouma, G., Thrasher, A. J., Batista, F. D., & Rawlings, D. J. (2008). Wiskott-Aldrich syndrome protein deficiency in B cells results in impaired peripheral homeostasis. Blood, 112 (10), 4158-69. doi:10.1182/blood-2008-02-140814
Peer Reviewed verified by ORBi

Humblet, S., Sather, B., Anover, S., Becker-Herman, S., Kasprowicz, D. J., Khim, S., Nguyen, T., Hudkins-Loya, K., Alpers, C. E., Ziegler, S. F., Ochs, H., Torgerson, T., Campbell, D. J., & Rawlings, D. J. (2007). Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis. Journal of Clinical Investigation, 117 (2), 407-18. doi:10.1172/JCI29539
Peer Reviewed verified by ORBi

Yu, P. W., Tabuchi, R. S., Kato, R. M., Astrakhan, A., Humblet, S., Kipp, K., Chae, K., Ellmeier, W., Witte, O. N., & Rawlings, D. J. (2004). Sustained correction of B-cell development and function in a murine model of X-linked agammaglobulinemia (XLA) using retroviral-mediated gene transfer. Blood, 104 (5), 1281-90. doi:10.1182/blood-2003-09-3044
Peer Reviewed verified by ORBi

Baron, F., Schaaf-Lafontaine, N., Humblet-Baron, S., Meuris, N., Castermans, E., Baudoux, E., Frere, P., Bours, V., Fillet, G., & Beguin, Y. (2003). T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation. Transplantation, 76 (12), 1705-13. doi:10.1097/01.TP.0000093987.11389.F7
Peer Reviewed verified by ORBi

Humblet-Baron, S., Baron, F., Chachati, A., Bury, J., Morelon, E., Kreis, H., & BEGUIN, Y. (2003). Donor lymphocyte infusion for late relapse followed by kidney transplantation for end-stage renal failure after allogeneic bone marrow transplantation for chronic myeloid leukemia. Transplantation, 76 (10), 1531-2. doi:10.1097/01.TP.0000085285.59061.D7
Peer Reviewed verified by ORBi

Hafraoui, K., Humblet-Baron, S., Baron, F., Beguin, Y., & Fillet, G. (2003). Comment je traite ... la leucemie myeloide chronique (LMC). Revue Médicale de Liège, 58 (1), 7-12.
Peer reviewed

Humblet-Baron, S., Baron, F., Pirson, L., Beguin, Y., & Fillet, G. (28 August 2002). Traitement moléculaire du cancer: le STI571, un inhibiteur des tyrosines kinases. Revue Médicale Suisse, 60 (598), 1504-1508.
Peer Reviewed verified by ORBi

Contact ORBi